These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26427404)

  • 1. Mouse Models of Stargardt 3 Dominant Macular Degeneration.
    Barabas P; Gorusupudi A; Bernstein PS; Krizaj D
    Adv Exp Med Biol; 2016; 854():137-43. PubMed ID: 26427404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.
    Barabas P; Liu A; Xing W; Chen CK; Tong Z; Watt CB; Jones BW; Bernstein PS; Križaj D
    Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5181-6. PubMed ID: 23479632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Progress in Deciphering Importance of VLC-PUFA in the Retina.
    Bennett LD; Anderson RE
    Adv Exp Med Biol; 2016; 854():145-51. PubMed ID: 26427405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.
    Agbaga MP; Tam BM; Wong JS; Yang LL; Anderson RE; Moritz OL
    Invest Ophthalmol Vis Sci; 2014 May; 55(6):3669-80. PubMed ID: 24833735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of VLC-PUFA-deficient photoreceptor terminals.
    Bennett LD; Hopiavuori BR; Brush RS; Chan M; Van Hook MJ; Thoreson WB; Anderson RE
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(7):4063-72. PubMed ID: 24764063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetics and molecular pathology of Stargardt-like macular degeneration.
    Vasireddy V; Wong P; Ayyagari R
    Prog Retin Eye Res; 2010 May; 29(3):191-207. PubMed ID: 20096366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.
    Schori C; Agbaga MP; Brush RS; Ayyagari R; Grimm C; Samardzija M
    PLoS One; 2018; 13(1):e0190514. PubMed ID: 29293603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of reduced retinal VLC-PUFA on rod and cone photoreceptors.
    Bennett LD; Brush RS; Chan M; Lydic TA; Reese K; Reid GE; Busik JV; Elliott MH; Anderson RE
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3150-7. PubMed ID: 24722693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis of very long-chain polyunsaturated fatty acids in hepatocytes expressing ELOVL4.
    Agbaga MP; Logan S; Brush RS; Anderson RE
    Adv Exp Med Biol; 2014; 801():631-6. PubMed ID: 24664752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinal pathology and skin barrier defect in mice carrying a Stargardt disease-3 mutation in elongase of very long chain fatty acids-4.
    McMahon A; Butovich IA; Mata NL; Klein M; Ritter R; Richardson J; Birch DG; Edwards AO; Kedzierski W
    Mol Vis; 2007 Feb; 13():258-72. PubMed ID: 17356513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 mice.
    McMahon A; Butovich IA; Kedzierski W
    J Lipid Res; 2011 Jun; 52(6):1128-1138. PubMed ID: 21429867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant Stargardt Macular Dystrophy (STGD3) and ELOVL4.
    Logan S; Anderson RE
    Adv Exp Med Biol; 2014; 801():447-53. PubMed ID: 24664730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.
    Logan S; Agbaga MP; Chan MD; Kabir N; Mandal NA; Brush RS; Anderson RE
    Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5446-51. PubMed ID: 23509295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report.
    Gyening YK; Boris K; Cyril M; Brush RS; Nassogne MC; Agbaga MP
    Acta Neuropathol Commun; 2023 Aug; 11(1):131. PubMed ID: 37568198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Elovl4 Spinocerebellar Ataxia-34 Mutation 736T>G (p.W246G) Impairs Retinal Function in the Absence of Photoreceptor Degeneration.
    Agbaga MP; Stiles MA; Brush RS; Sullivan MT; Machalinski A; Jones KL; Anderson RE; Sherry DM
    Mol Neurobiol; 2020 Nov; 57(11):4735-4753. PubMed ID: 32780351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids.
    Agbaga MP; Brush RS; Mandal MN; Henry K; Elliott MH; Anderson RE
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12843-8. PubMed ID: 18728184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of ELOVL4 protein in very long chain fatty acid synthesis and retinal function.
    Harkewicz R; Du H; Tong Z; Alkuraya H; Bedell M; Sun W; Wang X; Hsu YH; Esteve-Rudd J; Hughes G; Su Z; Zhang M; Lopes VS; Molday RS; Williams DS; Dennis EA; Zhang K
    J Biol Chem; 2012 Mar; 287(14):11469-80. PubMed ID: 22199362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofuscin.
    Vasireddy V; Jablonski MM; Khan NW; Wang XF; Sahu P; Sparrow JR; Ayyagari R
    Exp Eye Res; 2009 Dec; 89(6):905-12. PubMed ID: 19682985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploinsufficiency is not the key mechanism of pathogenesis in a heterozygous Elovl4 knockout mouse model of STGD3 disease.
    Raz-Prag D; Ayyagari R; Fariss RN; Mandal MN; Vasireddy V; Majchrzak S; Webber AL; Bush RA; Salem N; Petrukhin K; Sieving PA
    Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3603-11. PubMed ID: 16877435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous Expression of Mutant ELOVL4 Leads to Seizures and Death in a Novel Animal Model of Very Long-Chain Fatty Acid Deficiency.
    Hopiavuori BR; Deák F; Wilkerson JL; Brush RS; Rocha-Hopiavuori NA; Hopiavuori AR; Ozan KG; Sullivan MT; Wren JD; Georgescu C; Szweda L; Awasthi V; Towner R; Sherry DM; Anderson RE; Agbaga MP
    Mol Neurobiol; 2018 Feb; 55(2):1795-1813. PubMed ID: 29168048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.